Newsletter February 2022

Issue: February 2022

CRISPR Craze:

2022 marks the 10th anniversary of a remarkable report that paved the way for the CRISPR gene editing revolution. The senior authors of that study – Jennifer Doudna and Emmanuelle Charpentier – shared the Nobel Prize in Chemistry in 2020 for developing the “genetic scissors” that has already been deployed in the clinic, curing a handful of patients with sickle-cell disease. But for all of its early success and promise, CRISPR has also been at the center of a major controversy. In 2018, gene-edited twin girls were born in China, which triggered an international firestorm.

Why You Should Break Up with Your Biobank – 2022

Turning to traditional biobanks for samples may seem like an easy choice, but it’s fraught with challenges. Sanguine is leading the #research revolution – changing how researchers access samples with a patient-centric approach focused on harnessing our extensive #patient database to quickly mobilize and recruit even the most challenging patient populations nationwide for on-demand, convenient, at-home sample collection based on your study needs. Here’s why we’re saying you should leave your biobank and team up with us to maximize your study success.